OTCBB:PRVCF
PreveCeutical Medical Inc. Stock News
$0.0160
-0.0009 (-5.33%)
At Close: May 17, 2024
PreveCeutical Provides Update on Management Cease Trade Order
08:32pm, Thursday, 16'th May 2024
Vancouver, British Columbia--(Newsfile Corp. - May 16, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is providing an update with respect t
PreveCeutical Announces Management Cease Trade Order
06:36pm, Thursday, 02'nd May 2024
Vancouver, British Columbia--(Newsfile Corp. - May 2, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces that the Company has misse
PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES & OBESITY DUAL GENE THERAPY PROGRAM
07:00am, Monday, 04'th Dec 2023
VANCOUVER, BC , Dec. 4, 2023 /PRNewswire/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is pleased to announce that it has started preparation
VANCOUVER, BC , Sept. 18, 2023 /PRNewswire/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is proud to announce that Endosane Pharmaceuticals
PreveCeutical Showcases Dynamic Evolution in AI Strategy
07:00am, Tuesday, 12'th Sep 2023
VANCOUVER, BC , Sept. 12, 2023 /PRNewswire/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), PreveCeutical Medical Inc. marks today as an importa
PreveCeutical Engages New to the Street for Production & Broadcasting Services
07:00am, Thursday, 31'st Aug 2023
VANCOUVER, BC , Aug. 31, 2023 /PRNewswire/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), announces that it has entered into a Service Agreemen
PreveCeutical Files Cyclic Peptides And Uses Thereof in the EU and Australia
07:00am, Monday, 24'th Jul 2023
VANCOUVER, BC , July 24, 2023 /PRNewswire/ - PreveCeutica l Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is pleased to announce that PreveCeutical is furthe
PreveCeutical Receives AU$315,338 Research & Development Tax Incentive Cash Refund
08:00am, Tuesday, 31'st Aug 2021
Vancouver, British Columbia--(Newsfile Corp. - August 31, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that it ha
PreveCeutical Provides Corporate Update
08:00am, Monday, 31'st May 2021
Vancouver, British Columbia--(Newsfile Corp. - May 31, 2021) - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is pleased to provide the following u
PreveCeutical Announces Debt Settlement and Conversion of Debt
07:59pm, Friday, 12'th Mar 2021
Vancouver, British Columbia--(Newsfile Corp. - March 12, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces that it has agreed to is
Accomplished Biophysicist Linnéa Olofsson, Ph.D. joins PreveCeutical
08:00am, Tuesday, 23'rd Feb 2021
Vancouver, British Columbia--(Newsfile Corp. - February 23, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is very pleased to announce
PreveCeutical Announces Completion of Pain Management Peptides Program
08:00am, Tuesday, 02'nd Feb 2021
Vancouver, British Columbia--(Newsfile Corp. - February 2, 2021) - PreveCeutical Medical Inc (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is pleased to announce the s
